RT @bajoelbillete: Sí, vale, sé que siempre estoy criticando cosas, pero para variar tengo que admitir que el estudio de seroprevalencia qu…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @astro_duque: Proud of Spain's researchers for carrying out this ambitious nationwide seroprevalence study, published today in the prest…
RT @pmarsupia: El estudio de seroprevalencia en España acaba de ser publicado en The Lancet, una de las revistas científicas más prestigios…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @SaludISCIII: 📢 Resultados finales del estudio de seroprevalencia #ENECOVID ⬇️ 📰 Resumen en #NoticiasISCIII ➡️ https://t.co/Hk5IKh1Bqj…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
After 250000 cases and 28000 deaths Spain has a seroprevalence for COVID of only 5%. 😕 Anyone still betting on herd immunity?? https://t.co/mLF7BgPRZ6
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @alexandraphelan: Spain's SARS-CoV-2 prevalence is just ~5% despite one of Europe's largest #covid19 epidemics, from study today in @The…
RT @LarkinFin: Prevalence of SARS-CoV-2 in Spain - The Lancet; “Seroprevalence was 5.0% ...The majority of the Spanish population is sero…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @alexandraphelan: Spain's SARS-CoV-2 prevalence is just ~5% despite one of Europe's largest #covid19 epidemics, from study today in @The…
RT @CMichaelGibson: Largest random #COVID19 seroprevalence study in Europe of >61,000 ppl from Spain. 5% with IgG abs. 1 in 3 asymptomatic…
RT @bajoelbillete: Sí, vale, sé que siempre estoy criticando cosas, pero para variar tengo que admitir que el estudio de seroprevalencia qu…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
Better to be a nerd than pretend herd immunity is possible right now. #HerdImmunity
Just a reminder, novel in "novel coronavirus", means it's new and we keep learning more about it. We may not reach herd immunity, so wear a mask, stay away from large crowds, especially indoors.
RT @kikollan: El estudio de prevalencia que hizo España es fantástico. Apenas existen otros a nivel nacional y —lo más importante— con una…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @astro_duque: Proud of Spain's researchers for carrying out this ambitious nationwide seroprevalence study, published today in the prest…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @alexandraphelan: Spain's SARS-CoV-2 prevalence is just ~5% despite one of Europe's largest #covid19 epidemics, from study today in @The…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @astro_duque: Proud of Spain's researchers for carrying out this ambitious nationwide seroprevalence study, published today in the prest…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
RT @bajoelbillete: Sí, vale, sé que siempre estoy criticando cosas, pero para variar tengo que admitir que el estudio de seroprevalencia qu…
This thread ⬇️
RT @astro_duque: Proud of Spain's researchers for carrying out this ambitious nationwide seroprevalence study, published today in the prest…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @kikollan: El estudio de prevalencia que hizo España es fantástico. Apenas existen otros a nivel nacional y —lo más importante— con una…
RT @alexandraphelan: Spain's SARS-CoV-2 prevalence is just ~5% despite one of Europe's largest #covid19 epidemics, from study today in @The…
RT @pmarsupia: El estudio de seroprevalencia en España acaba de ser publicado en The Lancet, una de las revistas científicas más prestigios…
RT @kikollan: El estudio de prevalencia que hizo España es fantástico. Apenas existen otros a nivel nacional y —lo más importante— con una…
RT @kikollan: El estudio de prevalencia que hizo España es fantástico. Apenas existen otros a nivel nacional y —lo más importante— con una…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @bajoelbillete: Sí, vale, sé que siempre estoy criticando cosas, pero para variar tengo que admitir que el estudio de seroprevalencia qu…
RT @pmarsupia: El estudio de seroprevalencia en España acaba de ser publicado en The Lancet, una de las revistas científicas más prestigios…
Todo el planeta alaba el estudio de seroprevalencia español. La verdad es que a los que nos gustan los datos y la estadística se nos cae la baba con él. https://t.co/d13NdeY3Av
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @pmarsupia: El estudio de seroprevalencia en España acaba de ser publicado en The Lancet, una de las revistas científicas más prestigios…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @devisridhar: My take-away is that antibodies may not be best way to track % of people exposed given they seem to fade after COVID in le…
RT @bajoelbillete: Sí, vale, sé que siempre estoy criticando cosas, pero para variar tengo que admitir que el estudio de seroprevalencia qu…
Top story: Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study - The Lancet https://t.co/mfrZePaDHg, see more https://t.co/dAOSFmIOYl
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
Well this isn't good. There goes the herd immunity theory.
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @pmarsupia: El estudio de seroprevalencia en España acaba de ser publicado en The Lancet, una de las revistas científicas más prestigios…
RT @devisridhar: My take-away is that antibodies may not be best way to track % of people exposed given they seem to fade after COVID in le…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @kikollan: El estudio de prevalencia que hizo España es fantástico. Apenas existen otros a nivel nacional y —lo más importante— con una…
RT @pmarsupia: El estudio de seroprevalencia en España acaba de ser publicado en The Lancet, una de las revistas científicas más prestigios…
RT @ABaronGG: Important nationwide study about antibodies and #COVID19 in Spain in @TheLancet. "Prevalence estimates remain low and are cle…
RT @bajoelbillete: Sí, vale, sé que siempre estoy criticando cosas, pero para variar tengo que admitir que el estudio de seroprevalencia qu…
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
RT @pmarsupia: El estudio de seroprevalencia en España acaba de ser publicado en The Lancet, una de las revistas científicas más prestigios…
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @astro_duque: Proud of Spain's researchers for carrying out this ambitious nationwide seroprevalence study, published today in the prest…
RT @pmarsupia: El estudio de seroprevalencia en España acaba de ser publicado en The Lancet, una de las revistas científicas más prestigios…
Herd immunity will not cut it. We have to be prepared for the long haul and not be lulled into false security by those that put profit above people.
RT @pmarsupia: El estudio de seroprevalencia en España acaba de ser publicado en The Lancet, una de las revistas científicas más prestigios…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @SaludISCIII: "Tener anticuerpos no indica inmunidad total. Puede haber más factores de protección, pero vemos pérdida de anticuerpos de…
RT @astro_duque: Proud of Spain's researchers for carrying out this ambitious nationwide seroprevalence study, published today in the prest…
Well, there you go. Herd immunity unachiveable ...
Aprovechen, que hoy en día si pones COVID en el título te publican hasta una redacción de 4º de la ESO.
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @kikollan: El estudio de prevalencia que hizo España es fantástico. Apenas existen otros a nivel nacional y —lo más importante— con una…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @MartinOlalla_JM: ENE-COVID permite dar una cota sup e inf la tasa de mortalidad por infectado (IFR) La sup sale de suponer que todo…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @kikollan: El estudio de prevalencia que hizo España es fantástico. Apenas existen otros a nivel nacional y —lo más importante— con una…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @CMichaelGibson: Largest random #COVID19 seroprevalence study in Europe of >61,000 ppl from Spain. 5% with IgG abs. 1 in 3 asymptomatic…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @pmarsupia: El estudio de seroprevalencia en España acaba de ser publicado en The Lancet, una de las revistas científicas más prestigios…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @pmarsupia: El estudio de seroprevalencia en España acaba de ser publicado en The Lancet, una de las revistas científicas más prestigios…